From October 1, 2017, the Human Medicines (Amendment) Regulations 2017 were amended to allow schools to purchase adrenaline auto-injectors (AAI) without a prescription, for emergency use on children who are at risk of anaphylaxis but whose own device is not available or not working.

This change applies to all primary and secondary schools (including independent schools) in the UK. Schools are not required to hold spare AAI(s) – this is a discretionary, non-statutory change.

The DH has published guidance to help schools that choose to keep emergency AAIs create a policy for using them.

The guidance advises that schools can purchase AAIs from a local pharmacy, without a prescription, provided the general advice relating to these transactions are observed: ie small quantities on an occasional basis and the school does not intend to profit from it.

Pharmacies will need a request signed by the principal or head teacher (ideally on headed paper) stating:

·       the name of the school

·       the purpose for which that product is required

·       the total quantity required.

A template letter which can be used for this purpose is available.


PHE updates guidance on managing common infections

PHE has updated its advice on ’Managing common infections: guidance for primary care’

NPA unveils national innovation programme

A series of service pilots, funded by the NPA, is seeking to demonstrate to commissioners what pharmacists can deliver


NHS negligence bill quadruples in a decade

The Government must take steps to rein in the increasing cost of clinical negligence claims as numbers rocket, NAO warns

PDA and NPA demand patient safety pledge

The PDA and NPA have appealed to the Department of Health’s Rebalancing Board to adopt a patient safety ’pledge’

PSNC paints pessimistic picture for the future

The impact of the funding cuts in England is going to hit contractors hard in November, PSNC has warned